Agios Pharmaceuticals, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 20.7M | 20.0M | 12.9M | 12.5M | 8.7M | 10.7M | 9.0M | 8.6M |
| Cost of Goods Sold | 2.7M | 3.1M | 3.1M | 3.0M | 2.4M | 1.3M | 783K | 3.1M |
| Gross Profit | 18.1M | 16.8M | 9.8M | 9.5M | 6.4M | 9.5M | 8.2M | 5.5M |
| R&D Expenses | 79.8M | 86.8M | 85.4M | 90.7M | 71.5M | 82.8M | 72.5M | 75.8M |
| Operating Expenses | 128.1M | 138.4M | 126.7M | 136.6M | 113.0M | 134.5M | 111.0M | 111.3M |
| Operating Income | -110.0M | -121.6M | -116.9M | -127.1M | -106.6M | -125.0M | -102.8M | -105.8M |
| Other Income / Gains | 10.9M | 12.5M | 13.4M | 15.0M | 17.3M | 19.6M | 1.10B | 9.7M |
| Net Income | -99.1M | -108.0M | -103.4M | -112.0M | -89.3M | -96.5M | 947.9M | -96.1M |
| EPS (Diluted) | -1.69 | -1.85 | -1.78 | -1.93 | -1.55 | -1.69 | 16.65 | -1.69 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.871 | 0.842 | 0.763 | 0.762 | 0.729 | 0.883 | 0.913 | 0.642 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 48.3M | 51.6M | 41.3M | 45.9M | 41.5M | 51.7M | 38.5M | 35.5M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 130.8M | 141.5M | 129.7M | 139.5M | 115.4M | 135.8M | 111.8M | 114.4M |
| Interest Income | 10.8M | 12.4M | 13.4M | 14.5M | 16.1M | 18.0M | 13.1M | 8.1M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 1.4M | 1.3M | 1.4M | 1.3M | 1.3M | 1.4M | 1.3M | 1.6M |
| Ebitda | -97.7M | -107.8M | -102.1M | -110.8M | -88.0M | -104.0M | 1.00B | -94.5M |
| Ebitdaratio | -4.712 | -5.398 | -7.924 | -8.893 | -10.086 | -9.695 | 111.823 | -10.972 |
| Operating Income Ratio | -5.303 | -6.089 | -9.074 | -10.201 | -12.22 | -11.653 | -11.469 | -12.283 |
| Income Before Tax | -99.1M | -109.1M | -103.4M | -112.0M | -89.3M | -105.4M | 1.00B | -96.1M |
| Income Before Tax Ratio | -4.777 | -5.462 | -8.031 | -8.994 | -10.233 | -9.823 | 111.673 | -11.157 |
| Income Tax Expense | 0 | -1.0M | 0 | 0 | 0 | -8.9M | 53.1M | 0 |
| Net Income Ratio | -4.777 | -5.411 | -8.031 | -8.994 | -10.233 | -8.996 | 105.747 | -11.157 |
| Epsdiluted | -1.69 | -1.85 | -1.78 | -1.93 | -1.55 | -1.69 | 16.22 | -1.69 |
| Weighted Average Shs Out | 58.8M | 58.3M | 58.1M | 57.9M | 57.5M | 57.2M | 56.9M | 56.8M |
| Weighted Average Shs Out Dil | 58.8M | 58.3M | 58.1M | 57.9M | 57.5M | 57.2M | 58.4M | 56.8M |